%0 Journal Article
%T Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
%A Jo Ann LeQuang
%A John Bisney
%A Joseph V. Pergolizzi
%A Jr
%A Robert B. Raffa
%A Robert Taylor
%A Jr
%J Archive of "Pain and Therapy".
%D 2018
%R 10.1007/s40122-018-0095-8
%X Molecular structure of tapentadol, described as an MOR-NRI agent (mu-opioid receptor agonist and norepinephrine reuptake inhibitor
%K Chronic pain
%K Chronic pain control
%K Low back pain
%K Osteoarthritis pain
%K Severe chronic pain
%K Tapentadol
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993688/